India’s pharma exports hit file $30 billion in FY25, US stays prime importer regardless of Trump tariff threats – Firstpost

India’s annual drug and pharmaceutical exports touched a file $30 billion in FY25, marking a 31 per cent surge in March. In keeping with The Hindu, the exports stood at $30467.32 million, 9.39 per cent larger than the $27851.70 million clocked in FY24.

Prescription drugs Export Promotion Council Director Normal Raja Bhanu famous that pharma exports touched $30 billion for the primary time, exceeding the FY25 goal of $29.38 billion. The efficiency within the sector within the month of March stood out probably the most.

Whereas the scarcity of generic prescribed drugs within the US markets initially raised hopes, US President Donald Trump’s announcement to impose
26 per cent tariffs on Indian exports raised issues. Nonetheless, it’s pertinent to notice that the Trump tariffs, that are at present on maintain for 90 days, didn’t apply to pharma exports.

In keeping with official knowledge, pharma exports in March rose 31.21 per cent YoY. The subsequent greatest performing month within the fiscal yr was January, when the exports rose 21.47 per cent to $2590.88 million ($2132.92 million).

The US stays the prime market

Regardless of Trump’s reciprocal tariff threats, the US continues to stay the most important marketplace for Indian pharma exports, accounting for greater than one-third of the commerce. The exports to the US had been 14.29 per cent at $8953.37 million. In the meantime, the UK, Brazil, France and South Africa had been different international locations within the prime 5 importing from India, however account for a mixed lower than 10.5 per cent of the exports.

There was a contraction of 1.78 per cent with regard to exports to South Africa. Throughout the 11 months of the fiscal yr, the highest 25 countries-markets the place the exports declined had been the United Arab Emirates (by 17.70 per cent); Turkey (16 per cent); Sri Lanka (14.60 per cent); The Netherlands (13.79 per cent), China (10.60 per cent) and Belgium (7.37 per cent). The decline in exports was 3.80 per cent to Mexico and 0.14 per cent to Thailand, official knowledge confirmed.

Relating to regional knowledge, NAFTA, Europe, and Africa had been three main areas, collectively amounting to 76 per cent of Indian pharma exports. Amongst areas the place the exports declined had been Africa (by 1.74 per cent) and North East Asia (4.30 per cent).

With inputs from businesses.